AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Sumatriptan in South Africa
1 product registered with SAHPRA — 0 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| IMIGRAN 20 mg NASAL SPRAY | 31/7.3/0197 | GlaxoSmithKline South Africa (Pty) Limited | suspended | 28 Jul 2023 |
Sumatriptan — SAHPRA Registration Details
SAHPRA (South Africa) has 1 registered product containing Sumatriptan, of which 0 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Sumatriptan registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.